CAS: 13862-28-7; Potassium Trifluoro(Methyl)Borate

该化合物是一种无机化合物,其特点是有,氟和钾,该物质具有三氟甲基组(-CF3),附于一个波子离子,有助于其独特的化学特性.作为一个borate,该物质通常表现出厌食行为,这意味着它可以参与与钾等钾等化合物的离子结合.三氟甲基组可以增强化合物的稳定性,影响其再活动,使其在各种化学应用中有用,包括作为有机合成中的试剂.钾离子在极地溶剂中提供溶解性,并能够促进化合物与其他异质物种的相互作用.

结构式图片

相似化合物

13061-96-6 1332481-37-4 882871-21-8

欧盟法规

C&L通报

合成工艺路线路线简述

    三甲基环三硼氧烷置于potassium Hydrogen Bifluoride,水体系中,用 乙腈 用作溶剂,化学反应 3.0H,以80%的收率获得甲基三氟硼酸钾
    参考文献:空气稳定的烷基三氟硼酸钾的b-烷基铃木-宫浦交叉偶联反应.
    标题:空气稳定的烷基三氟硼酸钾的b-烷基铃木-宫浦交叉偶联反应.
    摘要:取代的烷基三氟硼酸钾与芳基卤化物和芳基三氟甲磺酸酯的钯催化交叉偶联反应易于进行,产率中等至非常好.烷基三氟硼酸钾1,2和3A-E易于合成,并以空气稳定的结晶固体形式获得,可以长期保存.所有交叉偶联均在相同的反应条件下使用pdcl(2)(dppf).Ch(2)cl(2)作为催化剂在thf-H(2)o中在3当量的cs(2)存在下进行以co(3)为基.
    Doi:10.1021/jo0343331

    专利信息


    专利号:US-9168248-B2
    优先权日:2009-02-17
    标 题:Spiro compounds useful as inhibitors of stearoyl-coenzyme A delta-9 desaturase
    发明人:LACHANCE NICOLAS; LECLERC JEAN-PHILIPPE; LI CHUN SING; MORADEI OSCAR MIGUEL
    权利人:LACHANCE NICOLAS; LECLERC JEAN-PHILIPPE; LI CHUN SING; MORADEI OSCAR MIGUEL; MERCK CANADA INC
    摘要:Heteroaromatic compounds of structural formula (I) are selective inhibitors of stearoyl-coenzyme A delta-9 desaturase (SCD1) relative to other known stearoyl-coenzyme A desaturases. The compounds of the present invention are useful for the prevention and treatment of conditions related to abnormal lipid synthesis and metabolism, including cardiovascular disease, such as atherosclerosis; obesity; diabetes; neurological disease; metabolic syndrome; insulin resistance; and liver steatosis.

    专利号:US-9637498-B2
    优先权日:2013-08-23
    标 题:Substituted thieno[2,3-C]pyridazine-6-carboxamide analogs as positive allosteric modulators of the muscarinic acetylcholine receptor M4
    发明人:LINDSLEY CRAIG W; CONN P JEFFREY; WOOD MICHAEL R; POSLUSNEY MICHAEL S; TARR JAMES C; MELANCON BRUCE J
    权利人:UNIV VANDERBILT
    摘要:In one aspect, the invention relates to substituted 5-aminothieno[2,3-c]pyridazine-6-carboxamide analogs, derivatives thereof, and related compounds, which are useful as positive allosteric modulators of the muscarinic acetylcholine receptor M4 (mAChR M4); synthesis methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of treating neurological and psychiatric disorders associated with muscarinic acetylcholine receptor dysfunction using the compounds and compositions. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

    专利号:US-8383643-B2
    优先权日:2009-07-28
    标题 :Spiro compounds useful as inhibitors of stearoyl-coenzyme A delta-9 desaturase
    发明人:LECLERC JEAN-PHILIPPE; LI CHUN-SING; MORADEI OSCAR MIGUEL
    权利人:MERCK CANADA INC; LECLERC JEAN-PHILIPPE; LI CHUN-SING; MORADEI OSCAR MIGUEL
    摘要:Heteroaromatic compounds of structural formula (I) are selective inhibitors of stearoyl-coenzyme A delta-9 desaturase (SCD1) relative to other known stearoyl-coenzyme A desaturases. The compounds of the present invention are useful for the prevention and treatment of conditions related to abnormal lipid synthesis and metabolism, including cardiovascular disease, such as atherosclerosis; obesity; diabetes; neurological disease; metabolic syndrome; insulin resistance; and liver steatosis.

    专利号:CN-114574882-A
    优先权日:2022-03-28
    标题 :Method for the synthesis of ortho-position alkylarylpyridines by electrochemical oxidative dehydrogenation coupling

    专利号:US-9879022-B2
    优先权日:2014-04-04
    标题:Bicyclic-fused heteroaryl or aryl compounds
    发明人:TRZUPEK JOHN DAVID; LEE KATHERINE LIN; BUNNAGE MARK EDWARD; HAN SEUNGIL; HEPWORTH DAVID; LOVERING FRANK ELDRIDGE; MATHIAS JOHN PAUL; PAPAIOANNOU NIKOLAOS; PIERCE BETSY SUSAN; STROHBACH JOSEPH WALTER; WRIGHT STEPHEN WAYNE; ZAPF CHRISTOPH WOLFGANG; GAVRIN LORI KRIM; LEE ARTHUR; ANDERSON DAVID RANDOLPH; CURRAN KEVIN JOSEPH; DEHNHARDT CHRISTOPH MARTIN; SAIAH EDDINE; GOLDBERG JOEL ADAM; WANG XIAOLUN; HUANG HORNG-CHIH; VARGAS RICHARD; LOWE MICHAEL DENNIS; PATNY AKSHAY
    权利人:PFIZER
    摘要:Compounds, tautomers and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula Ia, n nas defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.

    专利号:CN-117343044-A
    优先权日:2023-09-15
    标题:Synthesis method of 2-methyl-1- (pyridine-2-yl) indole compound
    北京普瑞东方化学技术有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.bjpurechem.com
    企业联系电话:010-83993285👤
    📞北京普瑞东方化学技术有限公司 ⚠️参考联系方式
    联系人:冷先生
    电话:010-83993285
    手机:17610176018
    传真:010-63370219
    邮箱:sales@bjpurechem.com
    通信地址: 北京市海淀区西三环北路50号院6号楼豪柏大厦1708室
    邮编: 100048
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:北京市海淀区西三环北路50号院6号楼豪柏大厦1708室
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Toyota, S.; Iwanaga, T., Science of Synthesis, (2010) 45, 782.
    摘要:Davies, G. H. M.; Wisniewski, S. R., Science of Synthesis Knowledge Updates, (2021) 2, 159.
    摘要:Molander, G. A.; Ryu, D., Science of Synthesis: C-1 Building Blocks in Organic Synthesis, (2013) 2, 43.
    摘要:Molander, G. A.; Ryu, D., Science of Synthesis: C-1 Building Blocks in Organic Synthesis, (2013) 2, 44.
    摘要:Yi, C. S., Science of Synthesis: Catalytic Transformations via CH Activation, (2015) 1, 242.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知